CEPI Collaborates with University of Hong Kong to Develop Vaccine for COVID-19
Shots:
- CEPI reports its seventh COVID-19 vaccine project and will invest $620-000 to HKU for the development of vaccine candidate against COVID-19- making the total investment of CEPI’s in COVID-19 vaccine R&D to $24.3M
- CEPI will provide initial funding to HKU for preclinical testing of their vaccine candidate and will provide further funding for clinical testing- following the results of preclinical studies
- The collaboration is a result of the global call for proposals- issued by CEPI in early Feb- which invited funding applications for proven vaccine technology which can be used to develop a vaccine against COVID-19
Click here to read full press release/ article | Ref: CEPI | Image: CEPI
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com